Literature DB >> 20980210

Challenges and opportunities in oncoproteomics.

Julio E Celis1, José M A Moreira.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20980210      PMCID： PMC5527918          DOI： 10.1016/j.molonc.2010.10.001

Source DB:  PubMed          Journal:  Mol Oncol        ISSN： 1574-7891            Impact factor:   6.603


× No keyword cloud information.
  8 in total

1.  Challenges and opportunities in oncoproteomics.

Authors:  Julio E Celis; José M A Moreira
Journal:  Mol Oncol       Date:  2010-10-12       Impact factor: 6.603

2.  Tissue proteomics of the human mammary gland: towards an abridged definition of the molecular phenotypes underlying epithelial normalcy.

Authors:  José M A Moreira; Teresa Cabezón; Irina Gromova; Pavel Gromov; Vera Timmermans-Wielenga; Isidro Machado; Antonio Llombart-Bosch; Niels Kroman; Fritz Rank; Julio E Celis
Journal:  Mol Oncol       Date:  2010-10-08       Impact factor: 6.603

Review 3.  Reverse phase protein microarrays advance to use in clinical trials.

Authors:  Claudius Mueller; Lance A Liotta; Virginia Espina
Journal:  Mol Oncol       Date:  2010-10-16       Impact factor: 6.603

4.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Authors:  Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

Review 5.  MALDI imaging mass spectrometry--painting molecular pictures.

Authors:  Kristina Schwamborn; Richard M Caprioli
Journal:  Mol Oncol       Date:  2010-09-25       Impact factor: 6.603

Review 6.  Targeted nanoagents for the detection of cancers.

Authors:  Jason R McCarthy; Jayeeta Bhaumik; Mark R Karver; S Sibel Erdem; Ralph Weissleder
Journal:  Mol Oncol       Date:  2010-09-08       Impact factor: 6.603

Review 7.  Phosphoproteomics in cancer.

Authors:  H C Harsha; Akhilesh Pandey
Journal:  Mol Oncol       Date:  2010-09-26       Impact factor: 6.603

Review 8.  Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology.

Authors:  George S Karagiannis; Maria P Pavlou; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2010-09-16       Impact factor: 6.603
  8 in total
  1 in total

1.  Challenges and opportunities in oncoproteomics.

Authors:  Julio E Celis; José M A Moreira
Journal:  Mol Oncol       Date:  2010-10-12       Impact factor: 6.603
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.